| Literature DB >> 27286105 |
Humberto do Nascimento Barbosa1, Tiberio Moreno Siqueira1, Francualdo Barreto2, Leonardo Gomes Menezes3, Mauro Jose Catunda Luna3, Adriano Almeida Calado1.
Abstract
INTRODUCTION: There is a lack of studies in our national scenario regarding the results obtained by laparoscopic radical prostatectomy technique (LRP). Except for a few series, there are no consistent data on oncological, functional, and perioperative results on LRP held in Brazil. As for the LRP technique performed by extraperitoneal access (ELRP), when performed by a single surgeon, the results are even scarcer.Entities:
Mesh:
Year: 2016 PMID: 27286105 PMCID: PMC4920559 DOI: 10.1590/S1677-5538.IBJU.2015.0323
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Figure 1– Digital dissection of the pre-peritoneal area.
Figure 2– Port closure with an umbilical point “X” on each side of the optical trocar.
Figure 3Patient and surgical team positioning.
Figure 4Arrangement of ports when the first assistant surgeon is left-handed.
– Characterization of the entire sample.
| Total (n=115) | Group 1 (n = 57) | Group 2 (n = 58) | p | |
|---|---|---|---|---|
|
| 62.8 (±7.3) | 62.8 (±8.0) | 62.7 (±6.5) | 0.941t |
|
| 27.2 (±3.4) | 21.1 (±3.3) | 27.3 (±3.6) | 0.827t |
|
| 6.9 (±4.4) | 7.1 (±4.5) | 6.6 (±4.4) | 0.510t |
|
| 39.3 (±13.0) | 40.8 (±14.9) | 37.8 (±10.9) | 0.070t |
|
| 22 (19.1%) | 12 (21.1%) | 10 (17.2%) | 0.603 |
|
| 0.775F | |||
| T1b | 1 (0.9%) | 1 (1.8%) | - | |
| T1c | 93 (80.9%) | 45 (78.9%) | 48 (82.8%) | |
| T2a | 13 (11.3%) | 6 (10.5%) | 7 (12.1%) | |
| T2b | 8 (7.0%) | 5 (8.8%) | 3 (5.3%) | |
|
| 0.173F | |||
| 4 (2+2) | 1 (0.9%) | 1 (1.8%) | - | |
| 5 (2+3) | 1 (0.9%) | 1 (1.8%) | - | |
| 5 (3+2) | 3 (2.6%) | 1 (1.8%) | 2 (3.4%) | |
| 6 (3+3) | 58 (50.4%) | 23 (40.4%) | 35 (60.3%) | |
| 7 (3+4) | 34 (29.6%) | 18 (31.6%) | 16 (27.6%) | |
| 7 (4+3) | 12 (10.4%) | 9 (15.8%) | 3 (5.2%) | |
| 8 (3+5) | 1 (0.9%) | 1 (1.8%) | - | |
| 8 (4+4) | 5 (4.3%) | 3 (5.3%) | 2 (3.4%) |
SD = standard deviation; t = T-Student test; F = Fisher’s exact test; ICM = index of corporal mass
– D’Amico risk stratification groups for prostate cancer.
| Risk Escore | Total (n=115) | Group 1 (n = 57) | Group 2 (n = 58) | p |
|---|---|---|---|---|
| Low Risk | 48 (41.7%) | 19 (33.3%) | 29 (50.9%) | 0.171 |
| Intermediate Risk | 56 (48.7%) | 31 (54.4%) | 25 (43.1%) | |
| High Risk | 11 (9.6%) | 7 (12.3%) | 4 (6.9%) |
– Intraoperative and post-operative variables.
| Total (n=115) | Group 1 (n = 57) | Group 2 (n = 58) | p | |
|---|---|---|---|---|
|
| 21.9 (±6.2) | 23.3 (±6.9) | 20.7 (±5.2) | 0.027t (*) |
|
| 4 (±3.5%) | 2 (±3.5%) | 2 (±3.4%) | > 0.999F |
|
| 135.8(±34.3) | 139.5 (±32.8) | 132.3 (±35.7) | 0.269t |
|
| 178.4(±80.9) | 200.7 (±89.5) | 156.4 (±65.0) | 0.003M (*) |
|
| 5 (4.3%) | 3 (5.3%) | 2 (3.4%) | 0.679F |
|
| 2.2 (±0.5) | 2.3 (±0.7) | 2.0 (±0.2) | 0.022t (*) |
|
| 9.7 (±2.6) | 10.6 (±2.9) | 8.8 (±1.8) | <0.001M (*) |
T = T-Student test; F = Fisher’s exact test; M = Mann-Whitney test
– Complications according to Clavien-Dindo classification system.
| Complication | Total (n=115) | Group 1 (n = 57) | Group 2 (n = 58) | p |
|---|---|---|---|---|
|
| 83 (72.2%) | 40 (70.2%) | 43 (74.1%) | 0.924F |
|
| 14 (12.2%) | 6 (10.5%) | 8 (13.8%) | |
|
| 1 (0.9%) | 1 (1.8%) | 0 (0%) | |
|
| 2 (1.7%) | 2 (3.5%) | 0 (0%) | |
|
| 1 (0.9%) | 0 (0%) | 1 (1.7%) | |
|
| 1 (0.9%) | 0 (0%) | 1 (1.7%) | |
|
| 1 (0.9%) | 1 (1.8%) | 0 (0%) | |
|
| 1 (0.9%) | 1 (1.8%) | 0 (0%) | |
|
| 2 (1.7%) | 1 (1.8%) | 1 (1.7%) | |
|
| 2 (1.7%) | 1 (1.8%) | 1 (1.7%) | |
|
| 4 (3.5%) | 2 (3.5%) | 2 (3.4%) | |
|
| 2 (1.7%) | 1 (1.8%) | 1 (1.7%) | |
|
| 1 (0.9%) | 1 (1.8%) | 0 (0%) |
– Postoperative pathologic evaluation.
| Variables | Total (n = 111)* | Group 1 (n = 55) | Group 2 (n = 56) | P |
|---|---|---|---|---|
|
| 0.497F | |||
| 5 (2+3) | 1 (0.9%) | 1 (1.8%) | - | |
| 5 (3+2) | 2 (1.8%) | - | 2 (3.6%) | |
| 6 (3+3) | 34 (30.6%) | 18 (32.7%) | 16 (28.6%) | |
| 7 (3+4) | 51 (45.9%) | 22 (40.0%) | 29 (51.8%) | |
| 7 (4+3) | 15 (13.5%) | 9 (16.4%) | 6 (10.7%) | |
| 8 (4+4) | 4 (3.6%) | 2 (3.6%) | 2 (3.6%) | |
| 9 (4+5) | 4 (3.6%) | 3 (5.5%) | 1 (1.8%) | |
|
| 27 (24.5%) | 14 (26.4%) | 13 (22.8%) | 0.660 |
|
| 15 (13.5%) | 5 (9.1%) | 10 (17.9%) | 0.177 |
|
| 19 (17.1%) | 8 (16.4%) | 11 (17.9%) | 0.835 |
|
| 0.177 |
F = Fisher’s exact test
*= 02 cases with benign prostatic hyperplasia result were excluded and 02 cases in which the operative specimen were lost.
Postoperative Gleason.
| Postoperative Gleason | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |||||||||||
| 2+2 | N | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | ||||||||||
| % | 0.0% | 0.0% | 100% | 0.0% | 0.0% | 0.0% | 0.0% | 100% | |||||||||||
| 2+3 | N | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||||||
| % | 100% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100% | |||||||||||
| 3+2 | N | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 3 | ||||||||||
| % | 0.0% | 0.0% | 0.0% | 66.7% | 0.0% | 0.0% | 33.3% | 100% | |||||||||||
| 3+3 | N | 0 | 1 | 26 | 22 | 8 | 0 | 0 | 57 | ||||||||||
| % | 0.0% | 1.8% | 45.0% | 38.6% | 14% | 0.0% | 0.0% | 100% | |||||||||||
| 3+4 | N | 0 | 1 | 4 | 21 | 2 | 1 | 2 | 31 | ||||||||||
| % | 0.0% | 3.2% | 12.9% | 67.7% | 6.5% | 3.2% | 6.5% | 100% | |||||||||||
| 3+5 | N | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | ||||||||||
| % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100% | 0.0% | 100% | |||||||||||
| 4+3 | N | 0 | 0 | 2 | 4 | 4 | 1 | 1 | 12 | ||||||||||
| % | 0.0% | 0.0% | 16.7% | 33.3% | 33.3% | 8.3% | 8.3% | 100% | |||||||||||
| 4+4 | N | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 5 | ||||||||||
| % | 0.0% | 0.0% | 20.0% | 40.0% | 20.0% | 20.0% | 0.0% | 100% | |||||||||||
| Total | N | 1 | 2 | 34 | 51 | 15 | 4 | 4 | 111 | ||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
p-value = 0.001
– Incidence of PSM regarding the pathological stage.
| Surgical Margins | Pathological Stage | P | ||
|---|---|---|---|---|
|
|
|
|
| |
|
| 88 (91.7%) | 04 (26.7%) | 92 (82.9%) | 0.001F |
|
| 08 (8.3%) | 11 (73.4%) | 19 (17.1%) | |
|
| 96 (100%) | 15 (100%) | 111 (100%) | |
F = Fisher’s exact test
Incidence of PSM for groups 1 and 2.
| Surgical Margins | Pathological Stage | P | ||
|---|---|---|---|---|
|
|
|
|
| |
|
| ||||
| Negative | 44 (95.7%) | 02 (4.3%) | 46 (100%) | 0.027F |
| Positive | 06 (66.7%) | 03 (33.3%) | 09 (100%) | |
|
| ||||
|
|
|
|
| |
|
| ||||
| (Group 2) | pT2 | pT3 | Total | |
|
| ||||
| Negative | 44 (95.7%) | 02 (4.3%) | 46 (100%) | <0.001F |
| Positive | 02 (20.0%) | 08 (80.0%) | 10 (100%) | |
|
| ||||
|
|
|
|
| |
F = Fisher’s exact test
- Comparison of groups in relation to the final stage (only for patients with positive margins)
| Final stage | Total | |||
|---|---|---|---|---|
| pT2 n = 8 | pT3 n = 11 | N = 19 | ||
| Group | 1 | 6 (66.7%) | 3 (33.3%) | 9 (100%) |
| 2 | 2 (20.0%) | 8 (80.0%) | 10 (100%) | |
p-value = 0.070 (Fisher’s exact test)
Through the result above, a statistical trend can be observed, (p<0.10) difference between the groups (80% vs. 33%).